About empirica
empirica is a Healthcare company based in Bonn (Germany) founded in 1988, and was acquired by Century Therapeutics in July 2020. Research and consulting services are provided by empirica. empirica offers products and services including Research Services and Consultancy Services. Its focus areas include Services for Healthcare Providers and Consultancy Services. Its legal entity is Empirika, a.s.
Company details
Empirica was founded in 1988 and is based in Bonn, Germany. Research and consulting services are offered in sectors such as economics, policy, and technology. Operations focus on data analysis, market studies, and strategic advisory for public and private clients. Expertise is applied across European and international projects, with support delivered through empirica.com. The firm maintains a presence in advisory roles for institutions and businesses.
- Headquarters Bonn, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website empirica.com
- Social LinkedIn X
- Acquired by Century Therapeutics (Jul 2020)
- Legal Name Empirika, A.S.
- Latest Funding Round$166.27K (USD), Grant
May 2022
- InvestorsCentury Therapeutics
& 1 more
- Acquired byCentury Therapeutics
(Jul 2020)
Products & Services of empirica
empirica offers a comprehensive portfolio of products and services, including Research Services and Consultancy Services.
Services for data collection and analysis in innovation fields
Expert guidance on ICT and health sector challenges
Funding Insights of empirica
- Total Rounds 31
- Last Round Grant — $166,275
- First Round $3.05M
(Jan 2014)
- Investors Count 1
Latest 10 of 31 funding rounds of empirica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $166,275 | Grant | – | – | |
| Dec 2021 | Grant | – | – | ||
| Sep 2021 | $308,390 | Grant | – | – | |
| Feb 2021 | $505,293 | Grant | – | – | |
| Dec 2020 | Grant | – | – | ||
| Dec 2020 | $641,641 | Grant | – | – | |
| Aug 2020 | Grant | – | – | ||
| Feb 2020 | $265,334 | Grant | – | – | |
| Jan 2020 | $483,115 | Grant | – | – | |
| Dec 2019 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in empirica
empirica has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Century Therapeutics and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Developer of adult stem cells to develop therapies for cancer | 2018 | centurytx.com | Philadelphia, United States |
Investor details for empirica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of empirica
4 dated milestones of empirica across 34 years, from founding to its latest funding, stage changes and deals.
- Founded empirica is founded.
- Funding First funding round of $3.1M.
- Exit Acquired by Century Therapeutics.
- Funding Latest funding round, Grant, of $166K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Empirica
Complete news archive for empirica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about empirica
empirica was founded in 1988 and raised its 1st funding round 26 years after it was founded.
empirica is headquartered in Bonn, Germany. It is registered at Bonn, North Rhine-westphalia, Germany.
Empirica was founded in 1988 and is based in Bonn, Germany. Research and consulting services are offered in sectors such as economics, policy, and technology. Operations focus on data analysis, market studies, and strategic advisory for public and private clients. Expertise is applied across European and international projects, with support delivered through empirica.com. The firm maintains a presence in advisory roles for institutions and businesses.
empirica offers Research Services and Consultancy Services.
empirica has 2 investors. Key investors include Century Therapeutics, and European Union.
empirica operates through Empirika, A.S..
Yes. empirica was acquired by Century Therapeutics in July 2020.